CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters ...

Distinguished Performance Awards at Arkansas State University were presented to six staff members and one staff group for ...

Nucleai, an AI-powered spatial biomarker and diagnostics company, will showcase its expanded suite of solutions for antibody-drug conjugate (ADC) clinical trials at the 2025 American Society of ...

Tyler Benson, a SOC support manager, shared just how impactful his employer’s professional development perks can be.

QinetiQ US wins a $41 million, three-year task order to provide software and technology integration support for a counter-UAS project under the U.S. Army Combat Capabilities Development Command ...

Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in non-small ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences ... the treatment of chronic hepatitis B during a late breaking poster presentation at the European Association for the Study of the Liver ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

TORONTO--(BUSINESS WIRE ... company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the Company will present a ...

Late-Breaking scientific poster at the American Thoracic ... SARS-CoV-2 Infection/COVID-19 TORONTO--(BUSINESS WIRE)--#ARDS--Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company ...